Enhancing Detection of Human Trafficking Act

HR4669 — FEMA Act of 2025

FEMA becomes an independent, cabinet-level agency with a clarified all-hazards mission and consolidated federal leadership for preparedness, response, recovery, mitigation, and interoperable communications. The bill also rewrites large parts of the Stafford Act to speed repairs, expand assistance, strengthen mitigation, and publish new public dashboards for disaster spending and individual aid metrics. - Families and disaster survivors: Expands housing help with a FEMA Emergency Home Repair program, authorizes direct repair assistance, and extends some temporary assistance periods from 18 to 24 months. Noncongregate sheltering can be provided without a fixed address and states cannot require a credit card for hoteling. - State, Tribal, and local governments and utilities: Creates expedited Section 409 grants for repairing public and qualifying nonprofit facilities with a Federal share floor of 75% and incentives up to 85% for resilience. Offers small-disaster block grants equal to 80% of the estimated Federal public assistance share and sets a Tribal hazard-mitigation minimum of $75.0 million per year. - Private nonprofits and houses of worship: Treats private nonprofits and houses of worship as eligible for assistance without regard to religious character and expands nonprofit closeout and eligibility parity with governments.

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.

HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.

HR2102 — Major Richard Star Act

Establishes concurrent receipt for retirees with combat-related disabilities. This bill would let eligible retirees receive both military retired pay and veterans' disability compensation for the same months without the offset rules that currently reduce payments. - Families of disabled retirees: Veterans with combat-related disabilities would receive both retired pay and VA disability compensation for the same months, increasing their monthly household income. - Defense and VA payment rules: The bill would amend 10 U.S.C. 1413a and 10 U.S.C. 1414 to exempt retired pay from reductions under 38 U.S.C. 5304 and 5305 and add a clear monthly no-offset rule. - Implementation and technical changes: It renames and updates chapter sections, adjusts cross-references, and applies to payments beginning the first month after enactment.

HR2048 — Metastatic Breast Cancer Access to Care Act

Ends Social Security and Medicare waiting periods for people with metastatic breast cancer. This bill would add “metastatic breast cancer” to the Social Security Act provisions that remove the waiting period for disability insurance benefits and would waive the 24-month Medicare waiting period, allowing affected individuals to access disability benefits and Medicare coverage without those delays.

HR1229 — United States-Israel Defense Partnership Act of 2025

Would deepen U.S.-Israel defense cooperation by creating new joint programs, offices, and multi-year funding to develop and deploy counter-unmanned systems and other emerging defense technologies. - U.S. military and Department of Defense: Creates a United States–Israel Counter-Unmanned Systems Program and a program office, authorizes $150 million per year for 2026–2030, and requires annual unclassified reports. - U.S. and Israeli defense industries and tech firms: Authorizes joint research, testing, and procurement across artificial intelligence, cybersecurity, robotics, quantum, and automation with $50 million per year for 2026–2030 and a framework for cost sharing and intellectual property. - Regional partners and missile defense planners: Requires an assessment of integrated air and missile defense in the U.S. Central Command area with an unclassified report in 180 days and extends the War Reserves Stockpile Authority beyond January 1, 2029. Would authorize $150 million per year for counter-unmanned systems and $50 million per year for emerging technology cooperation from 2026–2030, and raises funding caps for anti-tunnel and counter-UAS programs through 2028.